Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication
Authors:
- M. StotzMSM. Stotz
- D. Thu¨mMlerDTD. Thu¨mMler
- M. Schu¨rChMSM. Schu¨rCh
- J.-C. RenggliJRJ.-C. Renggli
- A. UrwylerAUA. Urwyler
- H. ParggerHPH. Pargger
Open Access
- 17 September 2004
- journal article
- case report
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 93 (6) , 868-871
Abstract
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.Keywords
This publication has 17 references indexed in Scilit:
- Neuroleptic malignant syndrome in advanced Parkinson's diseaseMovement Disorders, 2001
- Neuroleptic Malignant Syndrome with Hypotonia: A Diagnostic ChallengeEuropean Neurology, 2001
- Neuroleptic malignant syndrome without fever: a report of three casesJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Neuroleptic malignant syndromeBritish Journal of Anaesthesia, 2000
- Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a catechol-O-methyl transferase inhibitorThe American Journal of Medicine, 2000
- Muscle changes in the neuroleptic malignant syndromeJournal of Clinical Pathology, 2000
- Neuroleptic malignant syndrome with normal creatine kinase1996
- Glutamate receptor antagonists for neuroleptic malignant syndrome and akitetic hyperthermic Parkinsonian crisisJournal of Neural Transmission, 1993
- Neuroleptic sensitivity in patients with senile dementia of Lewy body type.BMJ, 1992
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981